Cannabis Use Characteristics and Reasons for Product Choices Among Patients Accessing Treatment for Substance Use Disorders: A Mixed-Methods Study

Cannabis use characteristics (including motives for choosing products) are complex and nuanced in patients accessing SUD treatment. More work is needed to understand longitudinal relationships between use of different cannabis products and both harms and potential benefits.

Authors

Institutions

Publication Details

Journal
Cannabis
Published
2025-06-27
DOI
https://doi.org/10.26828/cannabis/2025/000309
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabis Use Characteristics and Reasons for Product Choices Among Patients Accessing Treatment for Substance Use Disorders: A Mixed-Methods Study

Leslie Buckley, Christian S. Hendershot, Rebecca Haines‐Saah, Justin Matheson et al.
Cannabis
Cannabis and Cannabinoid Research
article

Cannabis Use Characteristics and Reasons for Product Choices Among Patients Accessing Treatment for Substance Use Disorders: A Mixed-Methods Study

Leslie Buckley, Christian S. Hendershot, Rebecca Haines‐Saah, Justin Matheson, Stefan M. Kloiber, Matthew E. Sloan, Bernard Le Foll, Marcos Sanches, Ahmed N. Hassan, Harseerat Saini, Adam Zaweel, James MacKillop, Amy Porathl
article en

Abstract

Cannabis use characteristics (including motives for choosing products) are complex and nuanced in patients accessing SUD treatment. More work is needed to understand longitudinal relationships between use of different cannabis products and both harms and potential benefits.

CannabisVol. 8(2)
Florida State University (US), University of Southern California (US), Centre for Addiction and Mental Health (CA), Mental Health Research Institute (AU), University of Calgary (CA), King Abdulaziz University (SA), University of Toronto (CA), Children's Hospital of Eastern Ontario (CA), Scarborough Health Network (CA), Waypoint Centre for Mental Health Care (CA), McMaster University (CA)
Pfizer, International OCD Foundation, Max Bell Foundation, Indivior, GW Pharmaceuticals, Ontario Ministry of Health and Long-Term Care, Mental Health Commission, University of Toronto, National Institutes of Health, Department of Psychiatry, University of Toronto, Canadian Institutes of Health Research
Openalex Percentile: Top 83%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.